Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnostic Technologies is an Australian medical technology company specializing in the development of non-invasive tools for assessing muscle function and performance. The company is best known for its Grip-Ball technology and the DTI-200 system, which provide precise measurements of muscle strength and endurance. These technologies are utilized in clinical research and healthcare settings to monitor disease progression in conditions such as Duchenne muscular dystrophy and to assess age-related muscle loss like sarcopenia. By providing objective data on neuromuscular health, Diagnostic Technologies supports both therapeutic development and clinical management of muscle-related disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagnostic Technologies.